Pica

Disclaimer: This clinical reference is intended for informational purposes only and does not constitute medical advice. It is not a substitute for professional medical judgment, diagnosis, or treatment. Clinicians must always exercise their independent judgment, consider individual patient circumstances, and refer to the most current evidence and local guidelines. Patient care decisions should be made in consultation with a qualified healthcare professional.

Overview

• Definition: Pica is an eating disorder characterized by the persistent ingestion of non-nutritive, non-food substances for at least one month, inappropriate to the developmental level of the individual, and not part of a culturally accepted practice. Substances ingested can vary widely and include items such as soil/dirt (geophagia), ice (pagophagia), starch (amylophagia), hair (trichophagia), paint, paper, clay, ash, or soap.

  • DSM-5 Diagnostic Criteria:
    1. Persistent eating of non-nutritive, non-food substances over a period of at least 1 month.
    2. The eating of non-nutritive, non-food substances is inappropriate to the developmental level of the individual (typically diagnosed after 2 years of age).
    3. The eating behavior is not part of a culturally supported or socially normative practice.
    4. If the eating behavior occurs in the context of another mental disorder (e.g., intellectual disability, autism spectrum disorder, schizophrenia) or a medical condition (e.g., pregnancy), it is sufficiently severe to warrant additional clinical attention.

• Epidemiology:

  • Pica is challenging to quantify accurately due to underreporting and varied definitions.
  • Children: Most commonly seen in children, with prevalence estimates varying widely from 10% to 32% in young children (1-6 years old). It is more frequent in children with intellectual developmental disorders (IDD) and autism spectrum disorder (ASD), where rates can be as high as 25-50% in institutionalized settings.
  • Pregnancy: Common during pregnancy, with reported prevalence rates ranging from 8% to 65% globally, often specifically involving cravings for ice (pagophagia) or dirt (geophagia).
  • Adults: Less common in adults without IDD or other severe psychiatric conditions, but can occur in individuals with schizophrenia, obsessive-compulsive disorder (OCD), or severe nutritional deficiencies.
  • Socioeconomic Factors: More prevalent in individuals from lower socioeconomic backgrounds, possibly due to increased environmental exposure to certain substances (e.g., lead paint in older housing) and higher rates of nutritional deficiencies.

• Classification: Pica is generally not classified into formal "types" but rather described by the specific substance ingested. Common forms include:

  • Geophagia: Ingestion of soil, clay, or dirt.
  • Pagophagia: Ingestion of ice or freezer frost. Often associated with iron deficiency anemia.
  • Amylophagia: Ingestion of laundry starch, raw rice, or cornstarch.
  • Trichophagia: Ingestion of hair (can lead to trichobezoars).
  • Lithophagia: Ingestion of stones or pebbles.
  • Plumbophagia: Ingestion of lead-containing substances (e.g., paint chips).
  • Coprophagia: Ingestion of feces (rare, often associated with severe IDD).
  • Other substances: Paper, ash, chalk, fabric, soap, paint, plaster, sand, coffee grounds.

Pathophysiology

• Mechanism: The exact pathophysiology of pica is multifactorial and often poorly understood, involving a complex interplay of nutritional, neurobiological, psychological, and environmental factors.

  • Nutritional Deficiencies: The most common hypothesis. Deficiencies in essential micronutrients, particularly iron and zinc, are strongly associated with pica. It is hypothesized that the body attempts to compensate for these deficiencies by craving and ingesting substances that may contain the missing minerals, or that the deficiency alters neurotransmitter systems. However, pica can also occur without any identifiable deficiency.
  • Neurobiological Factors:
    • Neurotransmitter Dysregulation: Imbalances in dopamine and serotonin pathways, similar to those seen in other compulsive disorders, may play a role. Pica may serve as a self-stimulatory or self-soothing behavior.
    • Lead Toxicity: Ingestion of lead-containing substances can cause or exacerbate pica, creating a vicious cycle where pica leads to lead exposure, which in turn may perpetuate pica behaviors.
  • Psychological Factors:
    • Developmental Disorders: In individuals with intellectual developmental disabilities or autism spectrum disorder, pica may be a sensory-seeking behavior, a coping mechanism for anxiety or stress, a result of impaired judgment, or a form of self-stimulation.
    • Mental Health Conditions: Pica can be observed in conditions like obsessive-compulsive disorder (OCD), schizophrenia, and depression, where it may represent a compulsive behavior, a delusional belief, or a coping strategy.
    • Stress and Trauma: Psychological stress, neglect, abuse, or maternal deprivation can sometimes be antecedents to pica behavior, particularly in children.
  • Environmental Factors: Exposure to contaminated environments (e.g., lead paint, contaminated soil) can contribute, especially in children. Lack of adequate food or stimulation can also be a factor.

• Risk Factors:

  • Nutritional Deficiencies: Iron deficiency anemia (most commonly implicated), zinc deficiency, calcium deficiency.
  • Developmental Disorders: Intellectual developmental disorder (IDD), autism spectrum disorder (ASD). Severity of IDD correlates with higher prevalence and persistence of pica.
  • Pregnancy: Hormonal changes, nutritional demands, and potential exacerbation of underlying deficiencies.
  • Mental Health Conditions: Schizophrenia, OCD, depression, anxiety disorders, eating disorders.
  • Socioeconomic Factors: Poverty, low parental education, neglect, inadequate supervision, poor housing conditions (e.g., lead paint).
  • Cultural Practices: While generally excluded from diagnosis, some culturally sanctioned practices (e.g., ceremonial ingestion of specific clays) can overlap or be difficult to differentiate.
  • Specific Substances: Exposure to lead, mercury, or other heavy metals in the environment.
  • Other Medical Conditions: Sickle cell disease (due to chronic anemia), gastrointestinal disorders.

• Protective Factors:

  • Adequate and balanced nutrition, including appropriate iron and zinc intake.
  • Early diagnosis and intervention for developmental delays and intellectual disabilities.
  • Safe home and school environments, free from hazardous non-food items.
  • Consistent parental supervision and engagement, especially for young children.
  • Access to mental health services for associated psychiatric conditions.
  • Education for caregivers on pica dangers and management.

Clinical Presentation

Signs and Symptoms

• Cardinal Features:
  • Reported or witnessed ingestion of non-nutritive, non-food substances.
  • Persistence of this behavior for at least one month.
  • The ingested substances are inappropriate for the individual's developmental level (typically >2 years old).
  • The behavior is not culturally or socially normative.
• Early Signs:
  • Parental or caregiver report of observed ingestion.
  • Presence of non-food items in the mouth of a child or adult.
  • Vague gastrointestinal symptoms such as abdominal pain, constipation, nausea, or decreased appetite without clear etiology.
  • Unexplained anemia (often iron-deficiency) or elevated lead levels on routine screening.
  • Oral lesions, excessive tooth wear, or gum irritation.
• Advanced Signs: These are typically complications of pica rather than the pica behavior itself.
  • Severe abdominal pain, vomiting, abdominal distension, absence of bowel movements (suggesting bowel obstruction or perforation).
  • Hematemesis or melena (gastrointestinal bleeding).
  • Symptoms of lead poisoning: Irritability, developmental regression, lethargy, poor appetite, constipation, abdominal pain, peripheral neuropathy (wrist/foot drop), encephalopathy (seizures, coma).
  • Symptoms of parasitic infection: Diarrhea, abdominal pain, weight loss, anal pruritus.
  • Dental damage: Chipped teeth, excessive wear, gingivitis.
  • Symptoms of other heavy metal toxicity (e.g., mercury, arsenic).
  • Bezoar formation: Palpable abdominal mass, early satiety, weight loss, halitosis.
  • Malnutrition or weight loss despite adequate food availability, due to substance ingestion displacing nutrient-rich food.
• Atypical Presentations:
  • Ingestion of highly dangerous substances (e.g., broken glass, sharp objects, highly toxic chemicals) without apparent distress or understanding of risk.
  • Covert pica where the individual hides the behavior, making diagnosis challenging.

Physical Examination

• Inspection:
  • Oral Cavity: Look for foreign bodies, dental erosion, chipped teeth, gingivitis, oral lesions, signs of excessive chewing.
  • Skin: Pallor (suggesting anemia), jaundice (liver damage from toxins), skin lesions or track marks (if injecting substances, highly unusual but possible), hair loss (trichophagia).
  • Abdomen: Distension, visible peristalsis, surgical scars (from previous foreign body removal), signs of peritonitis.
  • Neurological: Developmental delays or regression, motor deficits, altered mental status (especially with lead toxicity), signs of peripheral neuropathy.
• Palpation:
  • Abdomen: Tenderness, guarding, rebound tenderness (peritonitis), palpable mass (bezoar, foreign body, or fecal impaction).
  • Lymph Nodes: May be enlarged in cases of chronic infection.
• Special Tests: No specific diagnostic physical tests for pica itself, but evaluate for complications.
  • Neurological Exam: Assess for cognitive deficits, motor weakness, or sensory changes if heavy metal toxicity is suspected.
  • Growth Chart Review: In children, to identify failure to thrive or growth retardation.

Diagnostic Approach

History Taking

• Key Questions:
  • Substance Ingestion: What specific non-food substances are being ingested? How much? How often? For how long has this been occurring? Is it witnessed or suspected?
  • Duration and Frequency: When did the behavior start? Is it constant or intermittent?
  • Context: Under what circumstances does it occur? Alone, with others, in response to stress?
  • Associated Symptoms: Any gastrointestinal symptoms (abdominal pain, constipation, diarrhea, vomiting, bleeding), neurological changes, dental issues, weight changes?
  • Dietary History: Detailed dietary recall to assess for nutritional adequacy and deficiencies. Any food aversions or cravings?
  • Medical History: Previous diagnoses, surgeries, hospitalizations. Prior anemia or other nutritional deficiencies?
  • Developmental History: For children, milestones achieved, developmental delays, any diagnoses of IDD or ASD.
  • Psychiatric History: Diagnoses of anxiety, depression, OCD, schizophrenia, or other mental health conditions in children or adults.
  • Social History: Living environment (e.g., old paint, lead pipes, outdoor access to soil), socioeconomic status, family dynamics, potential for neglect or abuse.
  • Medication History: Current medications, supplements.
  • Family History: Any family members with pica or related psychiatric conditions?
  • Attempts to Intervene: What interventions have been tried by caregivers, and with what success?
• Red Flags:
  • Acute, severe abdominal pain, distension, or persistent vomiting (suggests obstruction or perforation).
  • GI bleeding (hematemesis, melena, hematochezia).
  • Neurological changes (lethargy, seizures, focal deficits, developmental regression) - highly concerning for lead encephalopathy.
  • Signs of significant heavy metal exposure (e.g., pallor, fatigue, unexplained GI symptoms).
  • Fever with abdominal symptoms (peritonitis, severe infection).
  • Ingestion of sharp objects, batteries, or other highly dangerous items.
  • Signs of neglect or abuse in a child.

Laboratory Tests

• First-Line:
  • Complete Blood Count (CBC) with differential: To screen for anemia (microcytic hypochromic anemia strongly suggests iron deficiency) and other cytopenias.
  • Iron Studies: Serum iron, total iron binding capacity (TIBC), transferrin saturation, and serum ferritin. Essential for diagnosing iron deficiency anemia, which is highly associated with pica.
  • Zinc Levels: Serum zinc can be checked, as zinc deficiency is also linked to pica.
  • Lead Levels: Crucial in all children (especially those < 6 years old) and pregnant women with pica, and in adults with suspected exposure. Venous blood sample preferred. Capillary samples need confirmation if elevated.
    • CDC Reference Value: Blood lead level of 3.5 mcg/dL (or 0.17 µmol/L) or higher is considered elevated. There is no safe blood lead level.
  • Stool Ova and Parasites (O&P): Especially if geophagia is present, to screen for parasitic infections (e.g., Toxocara canis, Ascaris lumbricoides, hookworm).
  • Basic Metabolic Panel (BMP): To assess electrolytes (especially if vomiting), renal function, and glucose.
  • Liver Function Tests (LFTs): To assess for liver injury from toxins.
  • C-Reactive Protein (CRP) / Erythrocyte Sedimentation Rate (ESR): Markers of inflammation, useful if infection or inflammatory bowel disease is suspected.
• Confirmatory:
  • No single "confirmatory" test for pica itself, but rather for its underlying causes or complications.
  • Repeated elevated lead levels confirm ongoing exposure.
  • Positive stool O&P confirms parasitic infection.
  • Response of pica to iron supplementation can support the diagnosis of iron-deficiency-associated pica.
• Monitoring:
  • Repeat CBC and iron studies after iron supplementation to confirm resolution of anemia.
  • Serial lead levels to monitor effectiveness of chelation therapy and reduction in exposure.
  • Repeat stool O&P after anti-parasitic treatment.
  • Monitor organ function (renal, hepatic) if heavy metal toxicity is confirmed.

Imaging

• Recommended:
  • Abdominal X-ray (Plain films - KUB): First-line imaging for suspected foreign body ingestion, bowel obstruction, or bezoar. Can detect radiopaque foreign bodies (e.g., coins, metal objects, lead chips, some stones). May show signs of obstruction (dilated loops, air-fluid levels) or perforation (free air under diaphragm).
• Advanced:
  • Computed Tomography (CT) Scan of the Abdomen/Pelvis: When plain films are inconclusive, or for more detailed assessment of obstruction, perforation, peritonitis, or to characterize bezoars. Can identify radiolucent foreign bodies.
  • Endoscopy (Esophagogastroduodenoscopy - EGD or Colonoscopy): For direct visualization and removal of foreign bodies in the upper or lower GI tract, or to evaluate for GI damage (e.g., ulcerations, erosions). Also used for bezoar diagnosis and fragmentation/removal.
  • Barium Studies (Upper GI Series): Less common due to risk of aspiration and obscuring subsequent imaging if perforation is present, but can visualize radiolucent foreign bodies or strictures. Not recommended if perforation is suspected.
  • Magnetic Resonance Imaging (MRI): Generally not preferred for acute foreign body localization due to potential for metallic objects to interfere, but can be useful for neurological complications related to heavy metal toxicity (e.g., lead encephalopathy).

Management

Acute Management

• Immediate: Prioritize airway, breathing, and circulation (ABCs) if the patient is acutely unwell.
  • Address life-threatening complications:
    • Airway obstruction: Emergency maneuvers (Heimlich), direct laryngoscopy.
    • Bowel obstruction/perforation: Rapid assessment, surgical consultation.
    • Severe lead poisoning (lead encephalopathy): Immediate chelation therapy.
    • Massive GI bleeding: Resuscitation, blood transfusion, urgent GI consultation.
• Stabilization:
  • Foreign Body Removal: Endoscopic removal for objects in the esophagus, stomach, or accessible parts of the small bowel/colon. Urgent surgical removal for non-endoscopically retrievable objects, sharp objects posing high perforation risk, button batteries in the esophagus, or confirmed obstruction/perforation.
  • Fluid and Electrolyte Management: Correct dehydration and electrolyte imbalances resulting from vomiting or poor intake.
  • Pain Management: Administer analgesics as needed for abdominal pain.
  • Antimicrobial Therapy: Broad-spectrum antibiotics if perforation or peritonitis is suspected.
• Emergency:
  • Surgical Intervention: Indicated for complete bowel obstruction, bowel perforation, intractable GI bleeding, or for removal of large or dangerous foreign bodies not amenable to endoscopy.
  • Chelation Therapy: For severe lead poisoning.
    • Blood Lead Level (BLL) > 45 mcg/dL: Initiate chelation.
    • BLL 45-69 mcg/dL: Oral succimer (DMSA) 10 mg/kg/dose TID for 19 days.
    • BLL ≥ 70 mcg/dL or lead encephalopathy: Parenteral chelation is required, typically with dimercaprol (BAL) 4 mg/kg IM every 4 hours, followed by calcium disodium EDTA (CaNa2EDTA) 1000-1500 mg/m² IV or IM per day divided every 6-12 hours, initiated 4 hours after the first BAL dose. Consult toxicology.

Chronic Management

• Pharmacological:
  • Nutritional Supplementation:
    • Iron Deficiency Anemia: First-line. Oral ferrous sulfate 325 mg (65 mg elemental iron) once to three times daily, depending on severity and tolerance. Adjust dosage for children by weight (e.g., 3-6 mg/kg/day of elemental iron). Continue for 3-6 months after anemia resolves to replenish stores.
    • Zinc Deficiency: Oral zinc supplementation (e.g., zinc gluconate 30-50 mg elemental zinc daily for adults, lower for children).
    • Multivitamins: May be considered to address other potential micronutrient deficiencies.
  • Psychotropic Medications:
    • Indications: Generally considered when behavioral interventions alone are insufficient, pica is severe and persistent, and especially if associated with underlying psychiatric disorders (e.g., OCD, schizophrenia, severe IDD with compulsive behaviors). Evidence specifically for pica is limited, often extrapolated from treatments for compulsive or impulsive disorders.
    • Atypical Antipsychotics: Risperidone, olanzapine, aripiprazole may be used to reduce compulsive behaviors in individuals with IDD or ASD, or for underlying psychosis. Doses vary by age and condition (e.g., risperidone 0.25-2 mg/day).
    • SSRIs (Selective Serotonin Reuptake Inhibitors): Fluoxetine, sertraline, fluvoxamine may be considered if pica is related to OCD or anxiety. Doses vary (e.g., fluoxetine 10-60 mg/day).
    • Naltrexone: An opioid antagonist, has shown some promise in reducing self-injurious behavior and pica in some individuals with IDD, possibly by reducing reinforcing effects. Doses typically 50-100 mg/day for adults.
  • Anti-parasitic Medications: If parasitic infection is confirmed by stool O&P (e.g., albendazole or mebendazole for intestinal nematodes).
• Non-pharmacological: Cornerstone of chronic management.
  • Behavioral Interventions (Applied Behavior Analysis - ABA):
    • Differential Reinforcement: Reinforce desired behaviors (e.g., playing with appropriate toys, eating food) while ignoring pica.
    • Response Blocking: Physically preventing the individual from ingesting the non-food item, used with caution and ethical considerations.
    • Taste Aversion: Pairing the pica substance with an unpleasant taste (e.g., bitter spray), typically for individuals with IDD.
    • Stimulus Control: Modifying the environment to remove access to pica substances.
    • Redirection: Providing acceptable alternatives or engaging in diverting activities.
  • Environmental Modifications:
    • Securely store or remove all non-food items that are being ingested, especially hazardous ones (e.g., lead paint, cleaning supplies).
    • Ensure a safe play and living environment for children.
  • Nutritional Counseling: Education on a balanced diet, proper food preparation, and the dangers of pica.
  • Psychological Support:
    • Cognitive Behavioral Therapy (CBT): For individuals capable of engaging in therapy, to address underlying psychological factors, coping mechanisms, and behavioral patterns.
    • Family Therapy/Caregiver Support: Educate caregivers, provide strategies for managing pica, and address family stress.
  • Occupational Therapy: May help with sensory integration issues or to provide appropriate sensory input for individuals with developmental disorders.
• Monitoring:
  • Regular clinical follow-up to assess pica frequency and severity, monitor for complications, and evaluate treatment efficacy.
  • Periodic re-evaluation of nutritional status and repeat laboratory tests (e.g., CBC, iron studies, lead levels) as indicated.
  • Monitor for side effects of any psychotropic medications.
  • Assess the home environment periodically for new pica hazards.

Treatment Algorithms

• First-Line:
  1. Rule out/treat underlying medical causes: Thorough history, physical, and lab evaluation for iron/zinc deficiency, lead poisoning, parasitic infections. Initiate appropriate supplementation or chelation.
  2. Environmental Modification: Remove access to pica substances. Ensure a safe environment.
  3. Behavioral Interventions: Implement targeted, individualized behavioral strategies (e.g., differential reinforcement, redirection) with caregiver education and support.
  4. Nutritional Counseling: Ensure adequate, balanced diet.
• Second-Line:
  1. Intensify Behavioral Therapy: If first-line behavioral interventions are insufficient, consider more intensive ABA approaches (e.g., response blocking, taste aversion if appropriate).
  2. Pharmacological Augmentation: If pica is severe, persistent, or associated with underlying psychiatric disorders (e.g., IDD, ASD, OCD, schizophrenia), consider psychotropic medications (e.g., atypical antipsychotics, SSRIs, naltrexone) in consultation with psychiatry, in addition to behavioral interventions.
• Refractory Cases:
  1. Multidisciplinary Team Approach: Involve developmental pediatricians, psychiatrists, psychologists, nutritionists, occupational therapists, social workers, and primary care providers.
  2. Re-evaluation: Thorough re-assessment for missed underlying causes, inadequate treatment, or new stressors.
  3. Alternative Pharmacological Agents: Explore other psychotropic options or combinations if initial trials fail, carefully weighing risks and benefits.
  4. Residential Treatment: In very severe, dangerous, and persistent cases, a specialized residential treatment program with intensive behavioral intervention may be considered.

Complications

• Common:
  • Iron Deficiency Anemia: Most frequent, especially with pagophagia or geophagia.
  • Constipation: From ingestion of indigestible substances.
  • Dental Damage: Enamel erosion, chipped teeth, gingivitis, tooth fractures.
  • Gastrointestinal Upset: Abdominal pain, nausea, vomiting, diarrhea.
  • Parasitic Infections: Especially with geophagia (e.g., Toxocara, Ascaris, hookworm).
• Serious:
  • Lead Poisoning (Plumbism): Highly dangerous, especially in children and pregnant women. Can lead to irreversible neurodevelopmental damage, anemia, renal failure, and severe abdominal pain (lead colic).
  • Bowel Obstruction: From large or indigestible foreign bodies, fecal impaction, or bezoars (e.g., trichobezoars, phytobezoars).
  • Bowel Perforation: Caused by sharp objects, leading to peritonitis, sepsis, and potentially death.
  • Bezoar Formation: Accumulation of indigestible material in the GI tract, leading to obstruction, malabsorption, or ulceration.
  • Other Heavy Metal Toxicity: Mercury, arsenic, cadmium poisoning.
  • Infections: Bacterial or viral infections from contaminated substances.
  • Malnutrition/Weight Loss: Ingested substances displace nutritious foods.
  • Electrolyte Imbalances: From persistent vomiting or severe diarrhea.
• Long-term:
  • Neurodevelopmental Delays/Cognitive Impairment: Primarily from chronic lead exposure.
  • Chronic Gastrointestinal Issues: Persistent abdominal pain, dyspepsia, malabsorption.
  • Recurrent Hospitalizations: Due to acute complications.
  • Chronic Anemia: If underlying pica or nutritional deficiencies are not adequately treated.
  • Psychological/Behavioral Impact: Social stigma, difficulty integrating into school/work environments.

Prognosis

• Factors:
  • Underlying Cause: Pica associated with temporary nutritional deficiencies (e.g., pregnancy-related iron deficiency) generally has a good prognosis with supplementation. Pica associated with severe IDD or complex psychiatric disorders tends to be more chronic and challenging to treat.
  • Age: Pica often resolves spontaneously in young children as they mature and develop greater discriminatory abilities. It tends to be more persistent in older children and adults, especially those with developmental or psychiatric comorbidities.
  • Severity and Type of Substance: Ingestion of highly toxic or dangerous substances carries a poorer prognosis due to severe complications.
  • Timeliness and Effectiveness of Intervention: Early identification and comprehensive management (nutritional, behavioral, environmental) significantly improve outcomes.
  • Caregiver Engagement: Consistent supervision and adherence to behavioral strategies by caregivers are crucial.
• Survival: Generally good if acute complications are promptly identified and effectively treated. Mortality is rare but can occur from severe complications such as bowel perforation, overwhelming heavy metal toxicity, or severe infection/sepsis.
• Quality of Life: Can be significantly impacted by chronic pica and its complications. This includes physical health (e.g., chronic abdominal pain, dental issues, neurological deficits), psychological well-being (e.g., anxiety, depression, social isolation), and functional outcomes (e.g., school performance, daily living activities). Resolution of pica can lead to significant improvements in overall health and quality of life.

Prevention

• Primary: Aimed at preventing the initial occurrence of pica.
  • Adequate Nutrition: Ensure balanced diet, especially for children and pregnant women. Routine screening for and supplementation of common deficiencies (iron, zinc) in at-risk populations.
  • Environmental Safety: Remove or secure access to non-food items, especially toxic ones (e.g., lead paint, cleaning supplies, medications). Provide safe play environments.
  • Education: Educate expectant parents, new parents, and caregivers about the dangers of pica, normal developmental mouthing behavior versus pica, and strategies for prevention.
  • Developmental Support: Early identification and intervention for developmental delays or disorders that may predispose to pica.
  • Psychosocial Support: Address risk factors like neglect or abuse by providing appropriate social services and support.
• Secondary: Focuses on early detection and prompt intervention to prevent complications and chronicity.
  • Routine Screening:
    • Nutritional Deficiencies: Screen at-risk individuals (e.g., pregnant women, toddlers, children with IDD) for iron deficiency anemia.
    • Lead Screening: Mandated lead screening in at-risk children (e.g., Medicaid-eligible, living in older housing) and targeted screening for others with potential exposure.
  • Caregiver Education: Educate caregivers on the signs of pica and the importance of seeking medical attention.
  • Prompt Evaluation: Investigate any reported or suspected pica behavior immediately to identify underlying causes and potential complications.
• Tertiary: Aimed at preventing recurrence and mitigating long-term complications in individuals already diagnosed with pica.
  • Comprehensive Management: Adherence to individualized treatment plans (nutritional, behavioral, pharmacological).
  • Ongoing Monitoring: Regular follow-up for pica behavior, nutritional status, and potential complications.
  • Environmental Modification: Continuous vigilance to maintain a safe environment.
  • Support Groups: For caregivers and individuals dealing with chronic pica, particularly in the context of developmental disabilities.

Special Populations

• Pediatric:
  • Prevalence: Most common in this age group, particularly toddlers (1-3 years) where mouthing objects is developmentally normal but needs careful differentiation from pica. Pica diagnosis usually after 2 years of age.
  • Risk: Highest risk for lead poisoning due to greater hand-to-mouth activity, immature blood-brain barrier, and higher absorption rate. Also higher risk for foreign body ingestion and parasitic infections.
  • Management: Emphasize environmental safety, parental education, and developmental assessment. Behavioral interventions are primary. Close monitoring for complications is essential.
• Geriatric:
  • Prevalence: Less common, often associated with severe dementia, profound cognitive impairment, or advanced psychiatric illness.
  • Risk: Increased risk of aspiration, choking, and complications due to frailty, comorbid medical conditions, and reduced physiological reserve. Dentition issues may also complicate ingestion and impact management.
  • Management: Focus on safety, environmental control within institutional settings (if applicable), nutritional assessment, and management of underlying cognitive/psychiatric conditions. Behavioral strategies must be adapted to cognitive capacity.
• Pregnancy:
  • Prevalence: Relatively common, often involving pagophagia or geophagia. Strong association with iron deficiency anemia.
  • Risk: Nutritional deficiencies can be exacerbated. Potential for maternal and fetal harm from ingested toxins (e.g., lead crosses the placenta and is neurotoxic to the fetus), infections, or GI complications.
  • Management:
    • Screening: Routine screening for iron deficiency anemia and lead levels.
    • Supplementation: Aggressive treatment of iron deficiency.
    • Counseling: Education about dangers to mother and fetus.
    • Pharmacology: Careful consideration of medication safety during pregnancy if psychotropic agents are needed for underlying psychiatric conditions.
• Comorbidities:
  • Intellectual Developmental Disorder (IDD) / Autism Spectrum Disorder (ASD):
    • Prevalence: Pica is significantly more prevalent and often more severe/persistent. Can be driven by sensory-seeking, self-stimulation, or communication deficits.
    • Management: Intensive, individualized Applied Behavior Analysis (ABA) is often the cornerstone. Environmental control and safety are paramount. Pharmacological interventions (e.g., atypical antipsychotics, naltrexone) may be considered in severe, refractory cases, especially if associated with aggression or self-injurious behavior. A multidisciplinary team is crucial.
  • Schizophrenia / Obsessive-Compulsive Disorder (OCD):
    • Prevalence: Pica can be a manifestation of psychosis, delusions, or severe compulsive behaviors.
    • Management: Treatment of the underlying psychiatric disorder with appropriate psychotropic medications (e.g., antipsychotics for schizophrenia, SSRIs for OCD) is key. Behavioral therapy tailored to the specific psychiatric condition is also important.

Clinical Pearls

• Diagnostic:
  • Always suspect pica in unexplained anemia (especially iron deficiency) or elevated lead levels in children and pregnant women. This is a critical association.
  • Be thorough in history taking, asking about unusual cravings or ingestion, even if patients deny them initially due to embarrassment or lack of awareness.
  • Consider pica in any patient with unexplained GI symptoms (abdominal pain, obstruction, bleeding) or dental issues.
  • Do not dismiss pica as "just a habit" without a complete medical and psychological workup.
  • Remember that pica can be covert, so look for indirect signs (e.g., substance residue, worn teeth, unexplained lab findings).
• Treatment:
  • Address the underlying cause first: Nutritional deficiencies must be corrected. If lead poisoning is present, chelation and environmental remediation are paramount.
  • Behavioral interventions are the cornerstone of treatment, particularly for individuals with developmental disabilities. Consistency and active caregiver involvement are critical.
  • A multidisciplinary approach is often necessary for complex or refractory cases, involving primary care, gastroenterology, toxicology, psychiatry, psychology, and social work.
  • Environmental control (removing access to pica substances) is a simple yet crucial first step in management.
• Pitfalls:
  • Missing serious complications: Overlooking symptoms of bowel obstruction/perforation or severe lead toxicity, which can be life-threatening.
  • Failing to screen for lead poisoning: A major error, especially in children and pregnant women, as lead's effects are devastating and irreversible.
  • Attributing pica solely to behavioral issues without investigating medical causes: This can lead to delayed diagnosis and treatment of conditions like iron deficiency or lead poisoning.
  • Dismissing parental or caregiver concerns: Listen carefully, as they are often the first to notice pica behaviors.
  • Inadequate follow-up: Pica often requires long-term monitoring and adjustment of interventions.

Recent Updates

• Guidelines:
  • DSM-5 (2013): Refined diagnostic criteria for pica, emphasizing its persistence, developmental inappropriateness, and non-cultural context. It also clarified that pica can be co-morbid with other mental or medical conditions.
  • CDC Guidelines for Lead Poisoning: Continual updates on blood lead reference values (most recently 3.5 mcg/dL as of 2021), screening recommendations, and management of lead-exposed children, which are directly relevant to pica management.
  • American Academy of Pediatrics (AAP): Periodically updates recommendations on lead screening, iron supplementation, and developmental screening, all of which impact pica management.
• Evidence:
  • Neurobiological Research: Ongoing studies are exploring the neural circuits and neurotransmitter systems (dopamine, serotonin) involved in pica, particularly in the context of developmental disorders, offering potential targets for future pharmacological interventions.
  • Behavioral Interventions: Further evidence supports the efficacy of individualized Applied Behavior Analysis (ABA) techniques for reducing pica behaviors in individuals with intellectual and developmental disabilities, with a focus on functional analysis to understand the purpose of the behavior.
  • Genetic Factors: Emerging research is investigating potential genetic predispositions to pica, although specific genes remain largely unidentified.
• Controversies:
  • Pharmacological Treatment for Idiopathic Pica: The role of psychotropic medications in pica not clearly linked to a primary psychiatric disorder remains an area of debate due to limited specific evidence and the potential for side effects.
  • Optimal Screening Strategy: While lead screening is clear, routine iron or zinc screening in all children or pregnant women for pica prevention is not universally adopted, leading to variability in practice.
  • Cultural Context: Differentiating culturally sanctioned ingestion of substances (e.g., specific clays for medicinal purposes) from pathological pica remains a nuanced and sometimes controversial diagnostic challenge, requiring careful clinical judgment and cultural sensitivity.

Key References

• Guidelines:
  • American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). American Psychiatric Publishing.
  • Centers for Disease Control and Prevention (CDC). Lead Poisoning Prevention Program. www.cdc.gov/nceh/lead/ (Regularly updated clinical guidelines and recommendations for lead screening and management).
  • American Academy of Pediatrics. Clinical Practice Guidelines on Screening for Elevated Blood Lead Levels. (Periodically updated).
  • World Health Organization (WHO). Guidelines on iron supplementation.
• Studies/Reviews:
  • Barton, J. R., & St Jeor, S. T. (1993). Pica. Nutrition in Clinical Practice, 8(3), 115-121. (Classic review)
  • Parra, J. H., & Morales, G. L. (2007). Pica during pregnancy: a review. Nutrition Research Reviews, 20(2), 205-212.
  • Miao, D., Young, R. C., & Kretchmer, N. (2000). Neurobiology of pica. The Journal of Pediatrics, 137(6), 803-808.
  • Callahan, J., & Hinkamp, D. L. (2013). Pica: Pathophysiology and Clinical Significance. Clinics in Laboratory Medicine, 33(2), 405-412.
  • Ruff, H. A., & Kales, S. N. (2016). Pica in children with autism spectrum disorder: a systematic review. Journal of Autism and Developmental Disorders, 46(12), 3747-3755.
  • Danford, D. E. (2015). Pica in Pregnancy: A Review of Risk Factors and Management. Clinical Obstetrics and Gynecology, 58(1), 162-171.
  • Levin, E. L., & Schoeber, J. (2013). Heavy Metal Toxicity in Children with Pica: A Case Study and Clinical Review. Pediatric Emergency Care, 29(4), 512-515.